BioSpace News Archive

Deals

Ironwood Pharmaceuticals Announces Adjustment of Conversion Rate for its 2.25% Convertible Senior Notes due 2020

Ironwood Pharmaceuticals, Inc. announced an adjustment to the conversion rate applicable to its existing 2.25% Convertible Senior Notes due 2022, effective April 15, 2019.

April 16, 2019
·
2 min read
Drug Development

Vaxart Doses First Patient in Randomized Cohort of Bivalent Norovirus Vaccine Phase 1b Clinical Trial

Vaxart, Inc. announced it has started dosing subjects in the randomized cohort of the Phase 1b bivalent norovirus vaccine clinical trial.

April 16, 2019
·
5 min read
Business

BC Platforms Selected to Deliver Enterprise Research Platform for Qatar Biobank

The agreement supports a vision of personalized healthcare to Qatar’s population and beyond

April 16, 2019
·
3 min read
Novus Health, Global Leader in Health Navigation, Takes Member Health and Safety on the Road with Travel Navigator™

For the past 13 years, Novus Health has helped organizations and their employees, members and customers navigate the complex health care systems around the world.

April 16, 2019
·
3 min read
Business

VIVUS to Host First Quarter Business Update and Financial Results Conference Call on Tuesday, April 30, 2019

The company will host a conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT the same day to review results and provide a business update.

April 16, 2019
·
1 min read
Motif Bio Presents New Iclaprim Data at ECCMID 2019

New iclaprim data are being presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2019) in Amsterdam, The Netherlands.

April 16, 2019
·
7 min read
Centrelake Medical Group, Inc. Provides Notice Of Data Incident

Centrelake Medical Group, Inc. is taking action after it recently became aware that there was an incident in which an unknown third party may have gained access to the data in its practice.

April 16, 2019
·
3 min read
Drug Development

Stealth BioTherapeutics Announces Positive Results for Elamipretide in Barth Syndrome Open-Label Extension Trial

Design and results from TAZPOWER and the TAZPOWER open-label extension were presented as late-breaking abstracts at the 2019 MDA Clinical & Scientific Conference

April 16, 2019
·
9 min read
Deals

ZGNX CLASS ACTION ALERT: Hagens Berman Alerts Zogenix (ZGNX) Investors to Securities Class Action, Encourages Investors to Contact the Firm

Hagens Berman Sobol Shapiro LLP alerts investors in Zogenix, Inc. to the securities class action pending in the United States District Court for the Northern District of California and to the June 11, 2019 Lead Plaintiff deadline.

April 16, 2019
·
2 min read
Business

SCCADVASA Launches Healthy Relationships Campaign Statewide to Recognize Sexual Assault Awareness Month

Eleven of SCCADVASA’s 22 member organizations will participate in statewide digital launch day

April 16, 2019
·
4 min read